Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Prospective, Cross-Sectional Clinical Performance Study of the in Vitro Diagnostic Device NK Vue Kit: Measurement of Natural Killer Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy

NCT02291198 is registered in ClinicalTrials.gov with ATGen Canada Inc as lead sponsor.

NCT NCT02291198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02291198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Prospective, Cross-Sectional Clinical Performance Study of the in Vitro Diagnostic Device NK Vue Kit: Measurement of Natural Killer Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy
Lead sponsor
ATGen Canada Inc
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
March 31, 2017
Enrollment
1,081 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

natural killer cell cytokine production